Fei Cao

431 total citations
32 papers, 293 citations indexed

About

Fei Cao is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fei Cao has authored 32 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 11 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fei Cao's work include Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Liver Disease Diagnosis and Treatment (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Fei Cao is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Liver Disease Diagnosis and Treatment (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Fei Cao collaborates with scholars based in China and Germany. Fei Cao's co-authors include Shuanggang Chen, Weijun Fan, Lujun Shen, Han Qi, Zhewei Zhang, Lin Xie, Jiaping Zheng, Jun Luo, Yi Yang and Duiping Feng and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Frontiers in Immunology.

In The Last Decade

Fei Cao

26 papers receiving 289 citations

Peers

Countries citing papers authored by Fei Cao

Since Specialization

Citations

This map shows the geographic impact of Fei Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Cao more than expected).

Fields of papers citing papers by Fei Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Cao. The network helps show where Fei Cao may publish in the future.

Co-authorship network of co-authors of Fei Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Cao. A scholar is included among the top collaborators of Fei Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Cao. Fei Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Impact of Microwave Ablation on Recurrence and Metastasis of Hepatocellular Carcinoma: Insights From Animal Studies and Cytokine Profiling 2025 ·Journal of Hepatocellular Carcinoma ·(unknown), (unknown), (unknown), Shuanggang Chen, (unknown), Han Qi, Lin Xie, Lujun Shen, Fei Cao, Weijun Fan	0
2	PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy 2025 ·Frontiers in Immunology ·Fei Cao, (unknown), (unknown), (unknown), Suyang Hao, Jinbin Chen, Shuanggang Chen, Lujun Shen, Lin Xie, Han Qi, Tao Huang, Yaojun Zhang, Zilin Huang	0
3	Exploring the mechanism of baicalein on breast cancer based on network pharmacology, molecular docking and in vivo experiments 2025 ·Toxicology and Applied Pharmacology ·(unknown), (unknown), (unknown), Fei Cao, (unknown), (unknown), Du‐Qiang Luo	0
4	Long-Term Analysis of Recurrence Beyond Milan Criteria Following Ablation of Solitary Early-Stage Hepatocellular Carcinoma ≤3 cm in Potentially Transplantable Patients: A Over 10-Year Survival Study 2025 ·Journal of Hepatocellular Carcinoma ·Shuanggang Chen, Han Qi, (unknown), Fei Cao, Lin Xie, Tao Huang, Ying Wu, (unknown), Yujia Wang, Lujun Shen, Weijun Fan	0
5	Cryoablation-induced neutrophil Ca2+ elevation and NET formation exacerbate immune escape in colorectal cancer liver metastasis 2024 ·Journal of Experimental & Clinical Cancer Research ·(unknown), Yiquan Jiang, Lujun Shen, (unknown), (unknown), Ling Gu, Yujia Wang, (unknown), Fei Cao, Tao Huang, Ying Liu, Weining Xie, Wuguo Deng, (unknown)	5
6	Survival path model outperforms conventional static machine learning models in long-term dynamic prognosis prediction for patients with intermediate stage hepatocellular carcinoma 2024 ·Bioinformatics Advances ·Lujun Shen, Jia‐Tao Zhang, Jian Xu, Yiquan Jiang, Fei Cao, Qifeng Chen, Chen Li, (unknown), Li Wang, Peihong Wu, Weijun Fan	0
7	Machine Learning for Dynamic Prognostication of Patients With Hepatocellular Carcinoma Using Time-Series Data: Survival Path Versus Dynamic-DeepHit HCC Model 2024 ·Cancer Informatics ·Lujun Shen, Yiquan Jiang, Jia‐Tao Zhang, Fei Cao, Liang‐Ru Ke, Chen Li, (unknown), Li Wang, Peihong Wu, Chaofeng Li, Qi Zeng, Weijun Fan	0
8	Neoadjuvant Chemoradiotherapy plus Sequential Tislelizumab Followed by Surgery for Esophageal Carcinoma (CRISEC study): A Prospective, Single-Arm, Phase II Trial 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Jun Yang, (unknown), Bin Wu, Chao Liu, Yuhan Qin, Lu Wen, Jian Wei, (unknown), (unknown), Yan Qu, Liming Huang, Xiaofei Wang, Bo Wang, Zhiyi Zuo, Fei Cao, Kewei Jiang, Kun Yang	1
9	Combined image-guided radiofrequency and iodine-125 seeds implantation in the treatment of recurrent hepatocellular carcinoma after hepatectomy 2024 ·BMC Cancer ·Fei Cao, (unknown), (unknown)	1
10	Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study 2023 ·BMC Cancer ·Fei Cao, (unknown), Guofu Zhang, (unknown), Jiaping Zheng, (unknown)	16
11	The relationship between the efficacy of thermal ablation and inflammatory response and immune status in early hepatocellular carcinoma and the progress of postoperative adjuvant therapy 2023 ·International Immunopharmacology ·Shuanggang Chen, (unknown), Ying Wu, Lujun Shen, Han Qi, Fei Cao, Tao Huang, (unknown), (unknown), Weijun Fan	3
12	Feasibility and efficacy of superconducting open-configuration magnetic resonance-guided microwave ablation of malignant liver tumors with real-time imaging sequences 2022 ·Journal of Cancer Research and Therapeutics ·Hui Yuan, Lujun Shen, (unknown), Xiucheng Wang, (unknown), Fei Cao, (unknown), (unknown), Yan Zhang, Ting Wang, Ying Wu, Weijun Fan	1
13	Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma 2022 ·Frontiers in Immunology ·Yujing Xin, Fei Cao, Hongcai Yang, (unknown), Yi Chen, Xiaojing Cao, (unknown), Xiao Li, (unknown)	35
14	The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study 2021 ·Frontiers in Oncology ·Fei Cao, Yi Yang, (unknown), Jun Luo, Hui Zeng, Zhewei Zhang, Duiping Feng, Yi Chen, Jiaping Zheng	66
15	Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard treatment regimens 2021 ·Journal of Cancer Research and Clinical Oncology ·Fei Cao, Jiaping Zheng, Jun Luo, Zhewei Zhang, Guoliang Shao	14
16	Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma 2020 ·Journal of Cancer Research and Therapeutics ·Shuanggang Chen, Lujun Shen, Zhiyu Qiu, Han Qi, Fei Cao, Lin Xie, Weijun Fan	8
17	Hepatocellular Carcinoma Within the Milan Criteria: A Novel Inflammation-Based Nomogram System to Assess the Outcomes of Ablation 2020 ·Frontiers in Oncology ·Shuanggang Chen, (unknown), Fei Cao, Lujun Shen, Han Qi, Lin Xie, Ying Wu, Weijun Fan	11
18	CT-guided percutaneous cryoablation combined with systemic chemotherapy for liver metastases from esophageal carcinoma: Initial experience 2019 ·Cryobiology ·Yan Wang, (unknown), Chang Xu, Fei Cao, (unknown), Wenge Xing, (unknown), Zhi Guo	6
19	<p>Efficacy Of Apatinib In Transcatheter Arterial Chemoembolization (TACE) Refractory Intermediate And Advanced-Stage Hepatocellular carcinoma：A Propensity Score Matching Analysis</p> 2019 ·Cancer Management and Research ·Zhiyu Qiu, Lujun Shen, Shuanggang Chen, Han Qi, Fei Cao, Lin Xie, Weijun Fan	19
20	Tree-based classification system incorporating the HVTT-PVTT score for personalized management of hepatocellular carcinoma patients with macroscopic vascular invasion 2019 ·Aging ·Fei Cao, Lujun Shen, Han Qi, Lin Xie, Ze Song, Shuanggang Chen, Weijun Fan	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact